Tradewinds LLC. Acquires New Holdings in Alpha Teknova, Inc. (NASDAQ:TKNO)

Tradewinds LLC. bought a new position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 43,550 shares of the company’s stock, valued at approximately $383,000.

Several other institutional investors and hedge funds also recently modified their holdings of the business. JPMorgan Chase & Co. boosted its stake in shares of Alpha Teknova by 622.5% during the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company’s stock valued at $37,000 after acquiring an additional 3,791 shares during the last quarter. Mount Lucas Management LP purchased a new position in Alpha Teknova in the 4th quarter valued at about $75,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Alpha Teknova during the 4th quarter worth about $94,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new stake in shares of Alpha Teknova during the fourth quarter worth about $180,000. Finally, Whalen Wealth Management Inc. acquired a new position in shares of Alpha Teknova in the fourth quarter valued at approximately $240,000. Hedge funds and other institutional investors own 13.81% of the company’s stock.

Alpha Teknova Stock Performance

Alpha Teknova stock opened at $5.19 on Wednesday. The stock has a fifty day moving average price of $7.16 and a 200 day moving average price of $7.01. Alpha Teknova, Inc. has a 52 week low of $1.16 and a 52 week high of $10.37. The firm has a market capitalization of $277.34 million, a P/E ratio of -7.01 and a beta of 0.41. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12.

Alpha Teknova (NASDAQ:TKNO) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.11) EPS for the quarter. The company had revenue of $9.27 million for the quarter, compared to analyst estimates of $9.10 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. Equities research analysts anticipate that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Analyst Ratings Changes

Separately, Craig Hallum assumed coverage on shares of Alpha Teknova in a research report on Monday, February 10th. They set a “buy” rating and a $12.00 target price on the stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.